Circulating CD4+CD28null T Cells May Increase the Risk of an Atherosclerotic Vascular Event Shortly after Kidney Transplantation

Proinflammatory CD4+ T cells without the costimulatory molecule CD28 (CD4+CD28null T cells) are expanded in patients with end-stage renal disease (ESRD) and associated with atherosclerotic vascular events (AVE). In a prospective study, the number of circulating CD4+CD28null T cells was established i...

Full description

Saved in:
Bibliographic Details
Main Authors: Michiel G. H. Betjes, Willem Weimar, Nicolle H. R. Litjens
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Journal of Transplantation
Online Access:http://dx.doi.org/10.1155/2013/841430
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832555973075533824
author Michiel G. H. Betjes
Willem Weimar
Nicolle H. R. Litjens
author_facet Michiel G. H. Betjes
Willem Weimar
Nicolle H. R. Litjens
author_sort Michiel G. H. Betjes
collection DOAJ
description Proinflammatory CD4+ T cells without the costimulatory molecule CD28 (CD4+CD28null T cells) are expanded in patients with end-stage renal disease (ESRD) and associated with atherosclerotic vascular events (AVE). In a prospective study, the number of circulating CD4+CD28null T cells was established in 295 ESRD patients prior to receiving a kidney allograft. Within the first year after transplantation, an AVE occurred in 20 patients. Univariate analysis showed that besides a history of cardiovascular disease (CVDpos, HR 8.1, ), age (HR 1.04, ), dyslipidaemia (HR 8.8, ), and the % of CD4+CD28null T cells (HR 1.04 per % increase, 95% CI 1.00–1.09, ) were significantly associated with the occurrence of a posttransplantation AVE. In a multivariate analysis, only CVDpos remained a significant risk factor with a significant and positive interaction between the terms CVDpos and the % of CD4+CD28null T cells (HR 1.05, 95% CI 1.03–1.11, ). Within the CVDpos group, the incidence of an AVE was 13% in the lowest tertile compared to 25% in the highest tertile of % of CD4+CD28null T cells. In conclusion, the presence of circulating CD4+CD28null T cells is associated with an increased risk for a cardiovascular event shortly after kidney transplantation.
format Article
id doaj-art-1ad5772be47b4e228f0574957ca82b04
institution Kabale University
issn 2090-0007
2090-0015
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Journal of Transplantation
spelling doaj-art-1ad5772be47b4e228f0574957ca82b042025-02-03T05:46:43ZengWileyJournal of Transplantation2090-00072090-00152013-01-01201310.1155/2013/841430841430Circulating CD4+CD28null T Cells May Increase the Risk of an Atherosclerotic Vascular Event Shortly after Kidney TransplantationMichiel G. H. Betjes0Willem Weimar1Nicolle H. R. Litjens2Erasmus Medical Center, Department of Internal Medicine, Division of Nephrology & Transplantation, D414, P.O. Box 2040, 3000 CA Rotterdam, The NetherlandsErasmus Medical Center, Department of Internal Medicine, Division of Nephrology & Transplantation, D414, P.O. Box 2040, 3000 CA Rotterdam, The NetherlandsErasmus Medical Center, Department of Internal Medicine, Division of Nephrology & Transplantation, D414, P.O. Box 2040, 3000 CA Rotterdam, The NetherlandsProinflammatory CD4+ T cells without the costimulatory molecule CD28 (CD4+CD28null T cells) are expanded in patients with end-stage renal disease (ESRD) and associated with atherosclerotic vascular events (AVE). In a prospective study, the number of circulating CD4+CD28null T cells was established in 295 ESRD patients prior to receiving a kidney allograft. Within the first year after transplantation, an AVE occurred in 20 patients. Univariate analysis showed that besides a history of cardiovascular disease (CVDpos, HR 8.1, ), age (HR 1.04, ), dyslipidaemia (HR 8.8, ), and the % of CD4+CD28null T cells (HR 1.04 per % increase, 95% CI 1.00–1.09, ) were significantly associated with the occurrence of a posttransplantation AVE. In a multivariate analysis, only CVDpos remained a significant risk factor with a significant and positive interaction between the terms CVDpos and the % of CD4+CD28null T cells (HR 1.05, 95% CI 1.03–1.11, ). Within the CVDpos group, the incidence of an AVE was 13% in the lowest tertile compared to 25% in the highest tertile of % of CD4+CD28null T cells. In conclusion, the presence of circulating CD4+CD28null T cells is associated with an increased risk for a cardiovascular event shortly after kidney transplantation.http://dx.doi.org/10.1155/2013/841430
spellingShingle Michiel G. H. Betjes
Willem Weimar
Nicolle H. R. Litjens
Circulating CD4+CD28null T Cells May Increase the Risk of an Atherosclerotic Vascular Event Shortly after Kidney Transplantation
Journal of Transplantation
title Circulating CD4+CD28null T Cells May Increase the Risk of an Atherosclerotic Vascular Event Shortly after Kidney Transplantation
title_full Circulating CD4+CD28null T Cells May Increase the Risk of an Atherosclerotic Vascular Event Shortly after Kidney Transplantation
title_fullStr Circulating CD4+CD28null T Cells May Increase the Risk of an Atherosclerotic Vascular Event Shortly after Kidney Transplantation
title_full_unstemmed Circulating CD4+CD28null T Cells May Increase the Risk of an Atherosclerotic Vascular Event Shortly after Kidney Transplantation
title_short Circulating CD4+CD28null T Cells May Increase the Risk of an Atherosclerotic Vascular Event Shortly after Kidney Transplantation
title_sort circulating cd4 cd28null t cells may increase the risk of an atherosclerotic vascular event shortly after kidney transplantation
url http://dx.doi.org/10.1155/2013/841430
work_keys_str_mv AT michielghbetjes circulatingcd4cd28nulltcellsmayincreasetheriskofanatheroscleroticvasculareventshortlyafterkidneytransplantation
AT willemweimar circulatingcd4cd28nulltcellsmayincreasetheriskofanatheroscleroticvasculareventshortlyafterkidneytransplantation
AT nicollehrlitjens circulatingcd4cd28nulltcellsmayincreasetheriskofanatheroscleroticvasculareventshortlyafterkidneytransplantation